Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

April 30, 2024

Study Completion Date

December 31, 2024

Conditions
COVID-19
Interventions
OTHER

Non Intervention

It's an observational study, no intervention involves.

Trial Locations (10)

Unknown

RECRUITING

Peking University First Hospital, Beijing

RECRUITING

Kwong Wah Hospital, Hong Kong

RECRUITING

Pamela Youde Nethersole Eastern Hospital, Hong Kong

RECRUITING

Princess Margaret Hospital, Hong Kong

RECRUITING

Queen Elizabeth Hospital, Hong Kong

RECRUITING

Queen Mary Hospital, Hong Kong

RECRUITING

The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong

RECRUITING

Tuen Mun Hospital, Hong Kong

RECRUITING

United Christian Hospital, Hong Kong

RECRUITING

Hospital Universitario de Torrejón, Torrejón de Ardoz

All Listed Sponsors
collaborator

Peking University First Hospital

OTHER

collaborator

Hospital Universitario de Torrejón

UNKNOWN

collaborator

Queen Mary Hospital, Hong Kong

OTHER

collaborator

Pamela Youde Nethersole Eastern Hospital

OTHER

collaborator

Queen Elizabeth Hospital, Hong Kong

OTHER

collaborator

United Christian Hospital

OTHER

collaborator

Kwong Wah Hospital

OTHER

collaborator

Princess Margaret Hospital, Hong Kong

OTHER_GOV

collaborator

Tuen Mun Hospital

OTHER_GOV

lead

Chinese University of Hong Kong

OTHER